NOVO NORDISK INC. for NOVO NORDISK INC.

Pharmacy PHA

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Taxation/Internal Revenue Code TAX

R&D tax credit generally; corporate tax inversion generally

Contacted: U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA)

Copyright/Patent/Trademark CPT

H.R. 9 Innovation Act (patent litigation and assertion)

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th)

Health Issues HCR

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); cost of diabetes

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 141 (114th), H.R. 1074 (114th), S. 84 (114th), S. 539 (114th), H.R. 1190 (114th), H.R. 2 (114th)

Medicare/Medicaid MMM

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Medicare diabetes screening generally; obesity medication and counseling coverage generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; Physician Quality and Reporting System (PQRS)

Contacted: Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); SENATE; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1726 (114th), H.R. 1021 (114th), H.R. 1686 (114th), H.R. 2 (114th)

Budget/Appropriations BUD

Issues related to National Diabetes Prevention Program in FY16 Labor/HHS/Education Appropriations and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC)

Bills named: H.Con.Res. 27 (114th), S.Con.Res. 11 (114th)

Trade (domestic/foreign) TRD

Trade Promotion Authority; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC)